MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer’s disease
Science · 15.09.2023 · 381 (6663) · 1176-1182
DOI: 10.1126/science.abp9556 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, erschienen am 15.09.2023. Verfasst von Sriram Balusu und 17 weiteren Autor:innen. Beteiligte Einrichtung: VIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium. Hauptthemen laut MEDLINE: Alzheimer Disease, Necroptosis, Neurons, RNA, Long Noncoding. Die Arbeit wurde bisher 244-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Alzheimer's Society, European Research Council.
Themen: Demenz
Abstract (Originalsprache)
Neuronal cell loss is a defining feature of Alzheimer’s disease (AD), but the underlying mechanisms remain unclear. We xenografted human or mouse neurons into the brain of a mouse model of AD. Only human neurons displayed tangles, Gallyas silver staining, granulovacuolar neurodegeneration (GVD), phosphorylated tau blood biomarkers, and considerable neuronal cell loss. The long noncoding RNA MEG3 was strongly up-regulated in human neurons . This neuron-specific long noncoding RNA is also up-regulated in AD patients. MEG3 expression alone was sufficient to induce necroptosis in human neurons in vitro. Down-regulation of MEG3 and inhibition of necroptosis using pharmacological or genetic manipulation of receptor-interacting protein kinase 1 (RIPK1), RIPK3, or mixed lineage kinase domain-like protein (MLKL) rescued neuronal cell loss in xenografted human neurons. This model suggests potential therapeutic approaches for AD and reveals a human-specific vulnerability to AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- VIB-KU Leuven Center for Brain and Disease Research, 3000 Leuven, Belgium.
- Leuven Brain Institute, KU Leuven, 3000 Leuven, Belgium.
- Achucarro Basque Center for Neuroscience, 48940 Leioa, Spain.
- Ikerbasque Basque Foundation for Science, 48009 Bilbao, Spain.
- Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, 431 80 Möndal, Sweden.
- Department of Psychiatry and Neurochemistry, Sahlgrenska Academy at the University of Gothenburg, 431 80 Möndal, Sweden.
ORCID-Profile: Sriram Balusu, Katrien Horré, Nicola Thrupp, Katleen Craessaerts, Lutgarde Serneels, Dries T'Syen, Iordana Chrysidou, Amaia M Arranz, Annerieke Sierksma, Joel Simrén, Thomas K Karikari, Henrik Zetterberg, Wei-Ting Chen, Dietmar Rudolf Thal, Mark Fiers, Bart De Strooper
Förderung
- Alzheimer's Society
- European Research Council
Zitieren
APA
Balusu, S., Horré, K., Thrupp, N., Craessaerts, K., Snellinx, A., Serneels, L., T'Syen, D., Chrysidou, I., Arranz, A. M., Sierksma, A., Simrén, J., Karikari, T. K., Zetterberg, H., Chen, W. T., Thal, D. R., Salta, E., Fiers, M., & De Strooper, B. (2023). MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer’s disease. Science, 381(6663), 1176-1182. https://doi.org/10.1126/science.abp9556
Vancouver
Balusu S, Horré K, Thrupp N, Craessaerts K, Snellinx A, Serneels L, et al. MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer’s disease. Science. 2023;381(6663):1176-1182. doi:10.1126/science.abp9556
BibTeX
@article{Balusu2023,
author = {Balusu, Sriram and Horré, Katrien and Thrupp, Nicola and Craessaerts, Katleen and Snellinx, An and Serneels, Lutgarde and T'Syen, Dries and Chrysidou, Iordana and Arranz, Amaia M and Sierksma, Annerieke and Simrén, Joel and Karikari, Thomas K and Zetterberg, Henrik and Chen, Wei-Ting and Thal, Dietmar Rudolf and Salta, Evgenia and Fiers, Mark and De Strooper, Bart},
title = {MEG3 activates necroptosis in human neuron xenografts modeling Alzheimer’s disease},
journal = {Science},
year = {2023},
volume = {381},
number = {6663},
pages = {1176--1182},
doi = {10.1126/science.abp9556}
}
EUVIMED